Deeper insight. Confident decisions.
Compounding returns.
Our top picks outperformed the ASX 200 by 4x. Independent, in-depth ASX equity research -- no conflicts, no games, just insights that work.
Deep Research
Detailed analysis across 450+ ASX companies, written to be clear and actionable
Portfolio Strategy
Model portfolios and sell signals to protect your downside
Verified Track Record
Bloomberg-sourced performance data you can trust
The Problem
Most investment research isn't built to help you.
It's built to sell you something.
And the numbers show it.
Conflicted brokers, conflicted advice
Broker research exists to generate trading commissions. Their "buy" call might be their sales team's next target. When the people writing research profit from your trades -- not your returns -- whose side are they really on?
Marketing disguised as analysis
Flashy headlines, bold price targets, and "hot stock picks" designed to get you clicking and trading. Strip away the marketing and most of it is a paragraph of opinion with nothing behind it.
Hope and prayer, not research
A one-page summary and a price target isn't research. Without understanding the business model, the financials, the risks, and what it's actually worth, you're investing on hope -- and hope isn't a strategy.
1,900+ companies left in the dark
Most brokers cover the ASX 50. Maybe the ASX 100. The other 1,900+ listed companies? Good luck finding any real analysis. You're on your own -- or you're guessing.
We built Alpha Insights to fix this. Better research. Honest research. Research that actually works.
How It Works
Three steps to better decisions.
1
Look up your companies.
Search any ASX company and get a full breakdown -- business model, financials, valuation, risks, and a fair value estimate. Know exactly what you own and what it's worth.
2
See our best ideas.
Browse our model portfolios -- the stocks we like most and the ones we'd avoid, with the reasoning behind every call.
3
Invest with confidence.
Use our research to guide your next move, or get a second opinion on what you already own. Either way, you walk away more informed and more confident.
What's Included
Everything you need to invest with confidence.
Featured
Portfolio Strategy Notes
Direct investment updates when it matters. Our October 2025 sell signal helped members avoid a 6% loss. Our January 2026 exit call sidestepped the Iran-driven market fall. Protecting your downside more than pays for itself.
Featured
Model Portfolios
The stocks we like most and the ones we'd avoid, backed by real performance data. A starting point for building your own portfolio, or use ours as a guide.
450+ Company Research Reports
Full company analysis through the Research Portal -- how the business makes money, its financial health, what it's worth, and the risks to watch out for.
Economic Intelligence
Periodic commentary on the economy, industries, and current affairs -- written in plain English so you understand what's happening and what it means for your investments.
Update & Comparison Alerts
When something important changes at a company, we update our research and show you exactly what changed, whether our view shifted, and why.
Inside a company research report -- valuation, financials, risk analysis, and member discussion
Track Record
Don't take our word for it. Look at the numbers.
What's the cost of not having the right research? In October 2025, we told members to sell and move to cash. The market dropped 6%. In January 2026, we called an exit before the Iran-driven fall. Members who followed our signals kept their gains while the market gave them back. One missed signal can cost more than years of membership.
Long Only -- Our Top Picks vs ASX 200
15 highest-conviction buy calls, Oct 14 2025 - Mar 2 2026
Our Top 15 Picks (+13.25%)
ASX 200 Benchmark (+3.39%)
Cash Rate (+1.09%)
Our top 15 buy ideas from the ASX 100, tracked from October 2025 to March 2026 using Bloomberg-verified prices. These are the stocks we liked most -- and how they actually performed.
Buying Winners, Avoiding Losers -- Combined Returns vs Cash
ASX 100, Oct 14 2025 - Mar 2 2026
Our Buy + Avoid Picks (+14.78%)
Cash Rate (+1.09%)
What if you bought the stocks we liked and avoided the ones we didn't? This chart shows exactly that -- equal portions of our buy and avoid picks, so the result comes purely from picking the right stocks, not from the market going up or down. It substantially outperformed leaving your money in cash.
Portfolio Strategy -- Sell Signals vs ASX 200
Timing calls overlaid on the S&P/ASX 200 Total Return, Oct 14 2025 - Mar 11 2026
Alpha Insights Strategy (+3.91%)
S&P/ASX 200 Total Return (-0.25%)
Sell Signal Active
The red zones show when we told members to sell and move to cash. By following these signals, members returned +3.91% while the ASX 200 lost -0.25% over the same period -- a difference of +4.15% just from knowing when to step aside.
Stocks We Said Buy
| Company | Our Call | Result |
|---|---|---|
| WGX Westgold Resources | Buy | +43.8% |
| BHP BHP Group | Buy | +38.5% |
| WDS Woodside Energy | Buy | +35.3% |
Stocks We Said Avoid
| Company | Our Call | Stock Move |
|---|---|---|
| ZIP Zip Co | Avoid | -62.4% |
| PME Pro Medicus | Avoid | -56.1% |
| XRO Xero | Avoid | -48.2% |
The model portfolio -- long and short positions side by side, with live performance tracking
Tracked from Oct 14, 2025 to Mar 2, 2026 (100 trading days). 87 ASX 100 companies covered. All prices sourced from Bloomberg (adjusted for dividends and stock splits). Past performance is not indicative of future results.
From the Founder
I spent 7 years as a buy-side equity research analyst. I know what good research looks like -- and I know how hard it is to find as a self-directed investor. So I built Alpha Insights to change that.
This isn't a side project. I left my career to build this full-time because I believe every investor deserves access to the same quality of analysis that institutional funds get. The proceeds also support a cause close to my heart -- funding prosthetic eyes for children with childhood cancer.
Ryan Lim
Founder, Alpha Insights
What Members Say
"The depth of analysis is outstanding. Alpha Insights genuinely feels like having a buy-side analyst on call."
Read the full review on ProductReview
"The more time I spend, the more I like it. A fantastic product."
"Your offering is far superior. I find your honesty refreshing."
"A much more thorough and professional product than others I've seen."
Is This For You?
Alpha Insights is for anyone who wants to invest with more confidence.
- You invest in ASX equities and want better research behind your decisions
- You want honest, independent research -- not research that's trying to sell you something
- You want to understand the bigger picture, not just get stock tips
- You'd rather understand what you own than guess and hope for the best
- You manage your own portfolio and want to be more informed and productive
Pricing
Institutional-grade research. A fraction of the price.
Most ASX research services charge $800-3,450/yr for 2-5 page reports on a handful of companies. We cover 450+ companies with 70+ page reports -- for less than $10 a week.
Premium
$500
per year -- 7-day free trial
- 450+ Company Research Reports
- Portfolio Strategy Notes
- Model Portfolios
- Economic Intelligence
- Update & Comparison Alerts
- Full Research Portal access
One good decision pays for years of membership. Not convinced after 7 days? Email [email protected]
Coming Soon
Meet Alfie -- the analyst in your corner.
Alfie knows every report in the Alpha Insights library. Ask it to compare stocks, check a company, get a second opinion on your portfolio, or find new investment ideas.
Alfie
Coming Soon
I own CSL and Cochlear -- how do they compare?
Both are quality companies, but both look expensive right now. Our research estimates CSL is trading about 72% above what we think it's worth, and Cochlear about 54% above. CSL is growing earnings faster, but Cochlear has a stronger competitive position. At these prices, neither is a bargain.
What are your best buy ideas right now?
Two that stand out: Westgold Resources (WGX) -- we think it's significantly undervalued and it's already up 43.8% since we flagged it. And Aurizon Holdings (AZJ), up 29.8%. Both generate strong cash flow and are trading well below what we think they're worth. BHP is also solid but getting closer to fair value.
FAQ
Frequently asked questions.
Our AI is a tool, not the analyst. It's guided by a professional analyst with 7 years of experience in funds management. Every valuation approach and research process is built on the same methods used by professional investors. The AI lets us cover more companies -- it doesn't replace the thinking. Every output is checked by a human, and all financial data is verified against Bloomberg.
We're independent -- no broker relationships, no commissions, no products to sell. Our research covers 450+ companies with the same depth you'd get from a professional analyst. Most services give you a price target and a paragraph. We give you the full breakdown -- how the business works, what it's worth, and what the risks are.
Our Portfolio Strategy Notes alone have called two major market downturns, helping members sidestep significant losses. One good decision pays for years of subscription.
Yes. Even if you hold 5 companies, having deep analysis on each one gives you confidence in what you own and clarity on when to act.
7-day free trial, cancel anytime. No lock-in, no exit fees. Email [email protected] if you have any issues.
Through the Research Portal -- a dedicated website for Premium members. Search any company, browse our model portfolios, and read economic updates. It works on desktop and mobile.
Company reports are updated whenever something important happens -- like earnings results, acquisitions, or major news. Economic commentary is periodic. Portfolio Strategy Notes go out whenever we see something you need to act on.
No. The research is written to be clear and actionable. If you invest in ASX stocks and want to be better informed, it's built for you.
Get Started
Deeper insight. Confident decisions. Compounding returns.
7-day free trial. Cancel anytime. No risk.
Questions? [email protected]